腋窝超声联合亚甲蓝示踪剂在乳腺癌前哨淋巴结活检术中的应用研究

doi:10.3969/j.issn.2095-378X.2019.03.005

外科研究与新技术 ›› 2019, Vol. 8 ›› Issue (3): 163-166.doi: 10.3969/j.issn.2095-378X.2019.03.005

腋窝超声联合亚甲蓝示踪剂在乳腺癌前哨淋巴结活检术中的应用研究

陈蔓青¹, 吴春山², 佘丹育², 方志潮³, 曾灿艺¹, 许丽珊¹

1.潮州市妇幼保健院乳腺疾病防治中心,潮州 521000;
2.潮州市中心医院超声科,潮州 521000;
3.潮州市人民医院胸心外科,潮州 521000

收稿日期:2019-05-05 出版日期:2019-09-28 发布日期:2019-12-05
作者简介:陈蔓青(1978—),女,大学本科,副主任医师,从事临床乳腺外科工作;电子信箱:drcmqing@163.com

Application of axillary ultrasound combined with methylene blue in sentinel lymph node biopsy of breast cancer

CHEN Manqing¹, WU Chunshan², SHE Danyu², FANG Zhichao³, ZENG Canyi¹, XU Lishan¹

1.Mammary Gland Disease Prevention and Control Center, Chaozhou Women’s and Children’s Hospital, Chaozhou 521000, China;
2.Department of Ultrasound, Chaozhou Central Hospital, Chaozhou 521000, China;
3.Cardiothoracic Surgery, Chaozhou People’s Hospital, Chaozhou 521000, China

Received:2019-05-05 Online:2019-09-28 Published:2019-12-05

摘要/Abstract

摘要： 目的研究术前腋窝超声联合术中亚甲蓝示踪剂显示淋巴引流导向,在腋窝淋巴结临床阴性的乳腺癌患者前哨淋巴结活检(SLNB)中的应用价值。方法纳入2015年4月—2019年3月接收的临床触诊阴性的乳腺癌患者(n=36)作为研究对象,在蓝染料法下行前哨淋巴结活检,并于术前行腋窝超声检查,对最低位、靠近乳腺的淋巴结进行标记,将其视为观察组,和术中前哨淋巴结位置及病理结果进行对照分析。对照组为同期乳腺癌手术患者(36例),在蓝染料法下行SLNB,术前未行淋巴结超声分析、体表标记。对两组检出率、准确性、特异性、敏感性进行研究。结果观察组腋窝前哨淋巴结检出率(97.22%)高于对照组(72.22%,P<0.05)。术前腋窝超声联合术中亚甲蓝对腋窝淋巴结状态检测的准确性为94.44%、敏感性为96.43%、特异性为77.78%。结论术前进行腋窝超声能够定位前哨淋巴结,较准确判断乳腺癌腋窝淋巴结转移的状况,减少单用亚甲蓝示踪剂时部分无蓝染的缺陷,降低假阴性发生率,值得借鉴,适合基层医院推广应用。

关键词: 术前腋窝超声, 乳腺癌, 前哨淋巴结活检, 亚甲蓝

Abstract: Objective To investigate the value of preoperative axillary ultrasound combined with methylene blue tracer to show lymphatic drainage in sentinel lymph node biopsy (SLNB) of breast cancer patients with clinically negative axillary lymph nodes.Methods From April 2015 to March 2019, breast cancer patients with clinically negative axillary lymph nodes (n=36) were selected as observation group, and were treated with SLNB by methylene blue staining method and axillary ultrasound before operation to mark lymph nodes at low level and near the breast; the intraoperative sentinel lymph node location and pathological Results were analyzed.Another 36 breast cancer patients were selected as control group during the same period to perform SLNB by methylene blue staining method, and no lymph node ultrasound analysis and body surface labeling were performed before the operation.The detection rate, accuracy, specificity, and sensitivity between the two groups were compared.Results The detection rate of sentinel lymph node in the observation group (97.22%) was higher than that in the control group (72.22%) (P<0.05).The accuracy, sensitivity, and specificity of axillary lymph nodes detected by preoperative axillary ultrasound combined with methylene blue were 94.44%, 96.43%, and 77.78%, respectively.Conclusion Preoperative axillary ultrasound can locate the sentinel lymph nodes, accurately determine the status of axillary lymph node metastasis in breast cancer, reduce the defect of partial absence of blue staining with methylene blue tracer alone, and reduce the incidence of false negative, which is suitable for promotion and application in primary hospitals.

Key words: Preoperative axillary ultrasound, Breast cancer, Sentinel lymph node biopsy, Methylene blue

中图分类号:

R737.9

陈蔓青, 吴春山, 佘丹育, 方志潮, 曾灿艺, 许丽珊. 腋窝超声联合亚甲蓝示踪剂在乳腺癌前哨淋巴结活检术中的应用研究[J]. 外科研究与新技术, 2019, 8(3): 163-166.

CHEN Manqing, WU Chunshan, SHE Danyu, FANG Zhichao, ZENG Canyi, XU Lishan. Application of axillary ultrasound combined with methylene blue in sentinel lymph node biopsy of breast cancer[J]. Surgical Research and New Technique, 2019, 8(3): 163-166.

参考文献

[1] 巫姜,赵戈,崔风强,等.前哨淋巴结活检联合术前超声在老年乳腺癌腋窝淋巴结清扫中的价值[J].现代肿瘤医学, 2016,24(4):551-554.
[2] 李英华,郭春龙,蒋健,等.早期乳腺癌前哨淋巴结活检术替代腋窝淋巴结清扫术的临床研究[J].中华内分泌外科杂志, 2015,9(2):106-108.
[3] 曹真真,卢明春.乳腺癌前哨淋巴结活检术与彩色多普勒超声诊断的临床价值分析[J].医学影像学杂志, 2017,27(8):1603-1605.
[4] 包蔚郁,白晓蓉,高晨,等.99TCm标记的亚锡植酸钠在乳腺癌腋窝前哨淋巴结活检术中的应用[J].中华肿瘤防治杂志, 2016,23(22):1507-1510.
[5] 陈思思,李小燕,江立玉,等.术前超声结合术中淋巴引流导向的乳腺癌精准前哨淋巴结活检[J].山东大学学报(医学版), 2018,56(1):50-56.
[6] 沈恩超,栗翠英,王聪,等.术前超声造影检查结合粗针穿刺活检对乳腺癌腋窝淋巴结评估的临床意义[J].中华实验外科杂志, 2017,34(2):285.
[7] 蒋蓓琦,章华,张志刚.腋窝超声在乳腺癌前哨淋巴结活检术中的应用价值[J].中华临床医师杂志, 2013,7(5):1975-1979.
[8] 钱立宇,钱军,李德群,等.染料法腋窝反向淋巴作图与前哨淋巴结活检在乳腺癌术中应用研究[J].中国实用外科杂志, 2015,35(2):208-210.
[9] 乐坚,周世崇,胡娜,等.超声引导细针穿刺结果与乳腺癌腋下转移性淋巴结数目的相关性研究[J].中国超声医学杂志, 2017,33(12):1067-1070.
[10] 王金礼,陈登峰.乳腺癌前哨淋巴结活检术的研究进展[J].河南医学研究, 2017,26(7):1206-1208.
[11] Clough K B, Nasr R, Nos C, et al.New anatomical classification of the axilla with implications for sentinel node biopsy[J].Br J Surg, 2010,97(11):1659-1665.
[12] 刘娟,马乐.前哨淋巴结活检在乳腺癌手术中的应用[J].浙江临床医学, 2017,19(11):2094-2095.
[13] 熊斌.川北医学院附属医院68例乳腺癌前哨淋巴结活检与腋窝淋巴结清扫术的临床分析[J].医药前沿, 2017,7(3):170-171.
[14] 刘旭,庞达.乳腺癌新辅助治疗后前哨淋巴结活检术应用的研究进展[J].现代肿瘤医学, 2017,25(8):171-175.
[15] 周丹,张昆,陈佩贤.吲哚菁绿荧光导航技术联合纳米炭在早期乳腺癌前哨淋巴结活检中的应用价值[J].天津医药, 2018,46(1):51-55.
[16] 张晨光,雪来提·派祖拉,伊丽娜,等.蓝染法联合核素示踪法在早期乳腺癌前哨淋巴结活检术中的应用及临床分析[J].转化医学电子杂志, 2017,4(6):29-35.
[17] 林伟.前哨淋巴结活检术在早期乳腺癌治疗中的疗效分析[J].现代实用医学, 2017,29(1):76-78.

腋窝超声联合亚甲蓝示踪剂在乳腺癌前哨淋巴结活检术中的应用研究

Application of axillary ultrasound combined with methylene blue in sentinel lymph node biopsy of breast cancer

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 12

编辑推荐

Metrics

本文评价

[1]	金海龙, 武彪, 张毅. 乳腺癌术后患者不同局部区域复发对预后的影响[J]. 外科研究与新技术, 2020, 9(3): 149-153.
[2]	吴松龄, 张美泽, 刘佳慧, 詹巧惠. 98例早期乳腺癌非前哨淋巴结转移的影响因素分析[J]. 外科研究与新技术, 2020, 9(1): 6-9.
[3]	王永亮, 柴辉, 赵宏卿, 王怀锦, 褚瑞军, 郭思亮, 翟耀君. 他莫昔芬与阿那曲唑乳腺癌内分泌治疗对于骨代谢水平的影响[J]. 外科研究与新技术, 2019, 8(4): 262-264.
[4]	陈文晓, 袁超杰, 吴卫文, 罗海岸. 溶脂辅助腋窝淋巴结清扫术临床应用分析[J]. 外科研究与新技术, 2019, 8(1): 40-43.
[5]	李燕玲, 刘佩蓉, 庄菊花, 陆伟华, 彭生. 耳穴揿针埋针对乳腺癌手术患者围手术期焦虑的护理干预[J]. 外科研究与新技术, 2018, 7(2): 143-145.
[6]	张辉, 林孟波, 王金泗, 陈晓耕, 范跃祖, 郑敏辉. 早期乳腺癌行保留乳头乳晕全乳切除术并一期乳房重建的治疗效果[J]. 外科研究与新技术, 2018, 7(1): 4-8.
[7]	徐明, 谢轶群, 朱佳慧, 黄斌. MiR-155和miR-21在乳腺癌分子亚型诊断中的价值[J]. 外科研究与新技术, 2017, 6(4): 229-234.
[8]	张辉, 林孟波, 王金泗, 陈晓耕, 范跃祖. 新辅助化疗对乳腺癌腋窝前哨淋巴结状况的影响[J]. 外科研究与新技术, 2017, 6(4): 235-238.
[9]	莫永泮, 杨毅. 乳腺外科整形术在乳腺癌保乳术中的应用价值[J]. 外科研究与新技术, 2017, 6(3): 155-157.
[10]	张涛施宝民王洪崔乃鹏林锐季堃. 乳腺癌前哨淋巴结阳性时非前哨淋巴结转移的相关因素分析[J]. 外科研究与新技术, 2017, 6(1): 1-4.
[11]	张涛施宝民王洪陈鹊汀季堃余松林. 乳腺癌T7 噬菌体展示cDNA文库的构建[J]. 外科研究与新技术, 2015, 4(1): 9-11.
[12]	陈权, 谭鸣. 一起“乳腺癌”病理报告失误导致的医疗事故分析[J]. 外科研究与新技术, 2012, 1(2): 169-170.